Risks of combining immunotherapy with targeted therapy, radiotherapy highlighted

Adding immune checkpoint inhibitors to targeted therapy or radiotherapy can worsen some of the toxic effects associated with these treatment modalities, indicate two reports published in JAMA Oncology.
Medwire News